Metabolic effects of Olanzapine versus Iloperidone: A 24 weeks randomized, prospective, interventional study

Journal Title: Internet Journal of Medical Update - Year 2016, Vol 11, Issue 2

Abstract

Atypical antipsychotics have become the mainstay of therapy for psychosis. Though extrapyramidal side effects have been reduced with atypical antipsychotics, yet there are increased concerns over metabolic effects. The present study is aimed to comparatively evaluate the metabolic profile of olanzapine and iloperidone in cases of psychosis. A prospective, randomized, open label, observational study of 6 months duration was conducted in the Department of Pharmacology and Department of Psychiatry, Rohilkhand Medical College and Hospital, Bareilly. A total of 62 patients of both sexes newly diagnosed with psychosis (ICD-10, F20- F29) were included in the study, 31 each in olanzapine and iloperidone groups. Demographic parameters were recorded, following which the patient’s body weight, BMI, fasting blood sugar and lipid profile were estimated at baseline. Follow-up of the patients was done periodically after one month, three months and six months. Olanzapine treated patients showed markedly significant rise in body weight up to 7 kg at the endpoint (p<0.0001) at each follow-up, with a significant increase in BMI. Rise in fasting blood sugar (FBS), total cholesterol (TC), triglycerides (TG) and low-density lipoprotein (LDL) levels werealso statistically significant. At the same time, significant decrease in HDL levels was also observed. Iloperidone treated patients showed statistically significant less rise in body weight (upto 1kg, p<0.05) and BMI. No significant changes in fasting blood sugar, total cholesterol, LDL and HDL levels were noted, while TG levels were significantly reduced. Iloperidone caused numerically less rise in bodyweight and BMI, and fewer metabolic adverse effects as compared to olanzapine, and hence should be preferred.

Authors and Affiliations

Shivangna Singh, Shalini Chandra, AK Kapoor, HK Singh, Rohit Kant

Keywords

Related Articles

Type II perforation of the body of the gallbladder in acalculous cholecystitis: a rare complication of enteric fever

Gallbladder perforation is a rare but potentially life-threatening complication of acute cholecystitis with or without gallstones. Enteric fever leading to small bowel perforation is rare, and gallbladder perforation is...

Evaluation of left ventricular structures in normotensive and hypertensive subjects by two-dimensional echocardiography: Anthropometric correlates in hypertension

This study was conducted with the objective to establish a nomogram for some left ventricular structures and their alterations in hypertension. Correlations between left ventricular structures and anthropometric variable...

STUDY OF HEALTH STATUS AND ETIOLOGICAL FACTORS OF MENTALLY CHALLENGED CHILDREN IN A SCHOOL FOR MENTALLY CHALLENGED IN MAHARASHTRA

The mental health of the child affects his physical health and the learning process. The present study was conducted to study the health status and etiological factors among 58 mentally challenged children in a school fo...

Cortical venous thrombosis – a rare complication of tuberculous meningitis&nbsp;

Occlusion of the central veins and sinuses occurs owing to thrombus, thrombophlebitis, or tumours. Cerebral venous thrombosis (CVT) is less frequent than arterial thrombosis, but can produce a cascade of sequelae and may...

Download PDF file
  • EP ID EP314531
  • DOI 10.4314/ijmu.v11i2.5
  • Views 72
  • Downloads 0

How To Cite

Shivangna Singh, Shalini Chandra, AK Kapoor, HK Singh, Rohit Kant (2016). Metabolic effects of Olanzapine versus Iloperidone: A 24 weeks randomized, prospective, interventional study. Internet Journal of Medical Update, 11(2), 17-24. https://europub.co.uk/articles/-A-314531